Oral Administration of Cytosolic PLA2 Inhibitor Arachidonyl Trifluoromethyl Ketone Ameliorates Cauda Equina Compression Injury in Rats

Overview

Journal J Neuroinflammation

Publisher Biomed Central

Date 2015 May 15

PMID 25971887

Citations 13

Authors

Mushfiquddin Khan

Anandakumar Shunmugavel

Tajinder S Dhammu

Fumiyo Matsuda

Avtar K Singh

Inderjit Singh

Affiliations

Soon will be listed here.

Abstract

Background: Phospholipase A2 (PLA2)-derived proinflammatory lipid mediators such as prostaglandin E2 (PGE2), leukotrienes B4 (LTB4), lysophosphatidylcholine (LPC), and free fatty acids (FFA) are implicated in spinal cord injury (SCI) pathologies. Reducing the levels of these injurious bioactive lipid mediators is reported to ameliorate SCI. However, the specific role of the group IVA isoform of PLA2 cytosolic PLA2 (cPLA2) in lumbar spinal canal stenosis (LSS) due to cauda equina compression (CEC) injury is not clear. In this study, we investigated the role of cPLA2 in a rat model of CEC using a non-toxic cPLA2-preferential inhibitor, arachidonyl trifluoromethyl ketone (ATK).

Methods: LSS was induced in adult female rats by CEC procedure using silicone blocks within the epidural spaces of L4 to L6 vertebrae. cPLA2 inhibitor ATK (7.5 mg/kg) was administered by oral gavage at 2 h following the CEC. cPLA2-derived injurious lipid mediators and the expression/activity of cPLA2, 5-lipoxygenase (5-LOX), and cyclooxygenase-2 (COX-2) were assessed. ATK-treated (CEC + ATK) were compared with vehicle-treated (CEC + VEH) animals in terms of myelin levels, pain threshold, and motor function.

Results: ATK treatment of CEC animals reduced the phosphorylation of cPLA2 (pcPLA2) determined by Western blot, improved locomotor function evaluated by rotarod task, and reduced pain threshold evaluated by mechanical hyperalgesia method. Levels of FFA and LPC, along with PGE2 and LTB4, were reduced in CEC + ATK compared with CEC + VEH group. However, ATK treatment reduced neither the activity/expression of 5-LOX nor the expression of COX-2 in CEC + VEH animals. Increased cPLA2 activity in the spinal cord from CEC + VEH animals correlated well with decreased spinal cord as well as cauda equina fiber myelin levels, which were restored after ATK treatment.

Conclusion: The data indicate that cPLA2 activity plays a significant role in tissue injury and pain after LSS. Reducing the levels of proinflammatory and tissue damaging eicosanoids and the deleterious lipid mediator LPC shows therapeutic potential. ATK inhibits cPLA2 activity, thereby decreasing the levels of injurious lipid mediators, reducing pain, improving functional deficits, and conferring protection against LSS injury. Thus, it shows potential for preclinical evaluation in LSS.

Citing Articles

Animal Models of Intervertebral Disc Diseases: Advantages, Limitations, and Future Directions.

Hong J, Kim H, Jeon W, Yeo C, Kim H, Lee J Neurol Int. 2024; 16(6):1788-1818.

PMID: 39728755 PMC: 11678881. DOI: 10.3390/neurolint16060129.

Comparing Brain and Blood Lipidome Changes following Single and Repetitive Mild Traumatic Brain Injury in Rats.

Pulliam A, Gier E, Gaul D, Moore S, Fernandez F, LaPlaca M ACS Chem Neurosci. 2024; 15(2):300-314.

PMID: 38179922 PMC: 10797623. DOI: 10.1021/acschemneuro.3c00603.

Fc Epsilon RI-Neuroimmune Interplay in Pruritus Triggered by Particulate Matter in Atopic Dermatitis Patients.

Isaifan D, Crovella S, Soubra L, Al-Nesf M, Steinhoff M Int J Mol Sci. 2023; 24(14).

PMID: 37511610 PMC: 10380572. DOI: 10.3390/ijms241411851.

Functions and mechanisms of cytosolic phospholipase A in central nervous system trauma.

Zhang H, Chen Y, Hu X, Cai W, Wang X, Ni W Neural Regen Res. 2022; 18(2):258-266.

PMID: 35900400 PMC: 9396495. DOI: 10.4103/1673-5374.346460.

Neuroprotective effects of Alda-1 mitigate spinal cord injury in mice: involvement of Alda-1-induced ALDH2 activation-mediated suppression of reactive aldehyde mechanisms.

Khan M, Qiao F, Kumar P, Touhidul Islam S, Singh A, Won J Neural Regen Res. 2021; 17(1):185-193.

PMID: 34100455 PMC: 8451565. DOI: 10.4103/1673-5374.314312.

References

Shimizu T . Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation. Annu Rev Pharmacol Toxicol. 2008; 49:123-50. DOI: 10.1146/annurev.pharmtox.011008.145616. View

Maihofner C, Nickel F, Seifert F . [Neuropathic pain and neuroplasticity in functional imaging studies]. Schmerz. 2010; 24(2):137-45. DOI: 10.1007/s00482-010-0902-6. View

Siebert E, Pruss H, Klingebiel R, Failli V, Einhaupl K, Schwab J . Lumbar spinal stenosis: syndrome, diagnostics and treatment. Nat Rev Neurol. 2009; 5(7):392-403. DOI: 10.1038/nrneurol.2009.90. View

Tran D, Duong S, Finlayson R . Lumbar spinal stenosis: a brief review of the nonsurgical management. Can J Anaesth. 2010; 57(7):694-703. DOI: 10.1007/s12630-010-9315-3. View

Kalyvas A, David S . Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron. 2004; 41(3):323-35. DOI: 10.1016/s0896-6273(04)00003-0. View

Golfman L, Haughey N, Wong J, Jiang J, Lee D, Geiger J . Lysophosphatidylcholine induces arachidonic acid release and calcium overload in cardiac myoblastic H9c2 cells. J Lipid Res. 1999; 40(10):1818-26. View

Zhang J, Barasch N, Li R, Sapirstein A . Inhibition of cytosolic phospholipase A(2) alpha protects against focal ischemic brain damage in mice. Brain Res. 2012; 1471:129-37. DOI: 10.1016/j.brainres.2012.06.031. View

Mollace V, Muscoli C, Masini E, Cuzzocrea S, Salvemini D . Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev. 2005; 57(2):217-52. DOI: 10.1124/pr.57.2.1. View

Watanabe K, Konno S, Sekiguchi M, Kikuchi S . Spinal stenosis: assessment of motor function, VEGF expression and angiogenesis in an experimental model in the rat. Eur Spine J. 2007; 16(11):1913-8. PMC: 2223356. DOI: 10.1007/s00586-007-0394-y. View

10.

Glennie R, Urquhart J, Staudt M, Lawendy A, Gurr K, Bailey C . The relationship between the duration of acute cauda equina compression and functional outcomes in a rat model. Spine (Phila Pa 1976). 2014; 39(19):E1123-31. DOI: 10.1097/BRS.0000000000000483. View

11.

Kuba T, Hunter D, Zhou L, Jenab S, Quinones-Jenab V . Endogenous gonadal hormones regulate females' behavioral responses to formalin through prostaglandin E2 release. Ethn Dis. 2010; 20(1 Suppl 1):S1-55-9. PMC: 6247909. View

12.

Inoue M, Xie W, Matsushita Y, Chun J, Aoki J, Ueda H . Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid. Neuroscience. 2008; 152(2):296-8. DOI: 10.1016/j.neuroscience.2007.12.041. View

13.

Leis H, Windischhofer W . Inhibition of cyclooxygenases 1 and 2 by the phospholipase-blocker, arachidonyl trifluoromethyl ketone. Br J Pharmacol. 2008; 155(5):731-7. PMC: 2584923. DOI: 10.1038/bjp.2008.304. View

14.

Liu N, Deng L, Zhang Y, Lu Q, Wang X, Hu J . Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injury. Ann Neurol. 2014; 75(5):644-58. PMC: 4320750. DOI: 10.1002/ana.24134. View

15.

Lucas K, Svensson C, Hua X, Yaksh T, Dennis E . Spinal phospholipase A2 in inflammatory hyperalgesia: role of group IVA cPLA2. Br J Pharmacol. 2005; 144(7):940-52. PMC: 1576074. DOI: 10.1038/sj.bjp.0706116. View

16.

Noguchi K, Okubo M . Leukotrienes in nociceptive pathway and neuropathic/inflammatory pain. Biol Pharm Bull. 2011; 34(8):1163-9. DOI: 10.1248/bpb.34.1163. View

17.

Farooqui A, Ong W, Horrocks L . Inhibitors of brain phospholipase A2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev. 2006; 58(3):591-620. DOI: 10.1124/pr.58.3.7. View

18.

Jaggi A, Jain V, Singh N . Animal models of neuropathic pain. Fundam Clin Pharmacol. 2009; 25(1):1-28. DOI: 10.1111/j.1472-8206.2009.00801.x. View

19.

Murphy E, Behrmann D, Bates C, Horrocks L . Lipid alterations following impact spinal cord injury in the rat. Mol Chem Neuropathol. 1994; 23(1):13-26. DOI: 10.1007/BF02858504. View

20.

Grewal S, Herbert S, Ponnambalam S, Walker J . Cytosolic phospholipase A2-alpha and cyclooxygenase-2 localize to intracellular membranes of EA.hy.926 endothelial cells that are distinct from the endoplasmic reticulum and the Golgi apparatus. FEBS J. 2005; 272(5):1278-90. DOI: 10.1111/j.1742-4658.2005.04565.x. View